我武生物股价涨5.4%，天弘基金旗下1只基金重仓，持有2.04万股浮盈赚取3.12万元

Group 1 - The core point of the news is that I-Wu Biotech's stock price increased by 5.4% to 29.88 CNY per share, with a total market capitalization of 15.645 billion CNY as of the report date [1] - I-Wu Biotech, established on September 19, 2002, and listed on January 21, 2014, specializes in the research, production, and sales of products for the diagnosis and treatment of allergic diseases [1] - The company's main revenue sources include dust mite drops (94.17%), Artemisia flower (4.35%), skin prick liquid (1.31%), R&D services (0.12%), and others (0.05%) [1] Group 2 - Tianhong Fund has a significant holding in I-Wu Biotech, with the Tianhong National Bio-Medical ETF holding 20,400 shares, representing 0.05% of the fund's net value, ranking as the ninth largest holding [2] - The Tianhong National Bio-Medical ETF, established on January 27, 2021, has a current size of 224 million CNY and has achieved a year-to-date return of 6.03%, ranking 3691 out of 4189 in its category [2] - The fund manager, He Yuxuan, has been in position for 4 years and 190 days, with the fund's total assets amounting to 9.413 billion CNY, achieving a best return of 101.32% and a worst return of -62.42% during the tenure [3]